AGENDA
Official title: Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients – A randomized placebo-controlled trial
Trial start year: 2007
Trial start year: 2007
Trial website
No website available
Design paper
2009
Rationale and design of the participant, investigator, observer, and
data-analyst-blinded randomized AGENDA trial on associations
between gene-polymorphisms, endophenotypes for depression and
antidepressive intervention: the effect of escitalopram versus
placebo on the combined dexamethasone-corticotrophine
releasing hormone test and other potential endophenotypes in
healthy first-degree relatives of persons with depression
Download full paper
Result paper
2011
Escitalopram and Neuroendocrine Response in Healthy
First-Degree Relatives to Depressed Patients – A
Randomized Placebo-Controlled Trial
Download full paper